Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...

Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...

Abbott Laboratories (NYSE:ABT) has caught investor attention with the FDA’s approval of an Investigational Device Exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System, a significant ...

John Baker, MD, cardiologist with West Tennessee Medical Group, recently performed the first procedure using the AGENT™ ...

An updated guideline has been published by the AHA, ACC, and other organizations regarding the management of acute coronary syndrome.

Coronary artery disease, a collective term for angina and heart attacks, is among the most common causes of death among women. A study published in Circulation, conducted by Tormod Rogne from Yale ...

People with HIV in Uganda do not have a higher prevalence of coronary artery disease compared to people without HIV. Among both groups, the prevalence of coronary artery disease was low compared to ...

While classic symptoms like chest pain are well-known, there are more surprising heart disease symptoms you need to pay ...

Awareness Day, and it’s a great opportunity to discuss lipids and howlipoprotein (a) might differ from your general ...

Recognizing the early signs of a blockage is crucial because early treatment can prevent severe complications.

Worldwide, millions of people are worried about increasing heart disease, which encompasses high blood pressure, coronary ...